Related Experiment Video

Updated: May 18, 2026

Real-Time Analysis of Bioenergetics in Primary Human Retinal Pigment Epithelial Cells Using High-Resolution Respirometry
09:16

Real-Time Analysis of Bioenergetics in Primary Human Retinal Pigment Epithelial Cells Using High-Resolution Respirometry

Published on: February 3, 2023

TAp73 depletion accelerates aging through metabolic dysregulation

Alessandro Rufini1, Maria Victoria Niklison-Chirou, Satoshi Inoue

  • 1Medical Research Council, Toxicology Unit, Leicester University, Leicester, United Kingdom.

Genes & Development
|September 19, 2012
PubMed

Insights

The protein TAp73 protects against aging by controlling mitochondrial function and reducing reactive oxygen species (ROS). TAp73-null mice exhibit accelerated aging, increased oxidative damage, and cellular senescence.

Area of Science:

  • Biogerontology
  • Molecular Biology
  • Cellular Biology

Background:

  • Aging is linked to reduced ability to clear reactive oxygen species (ROS).
  • Mitochondrial dysfunction and oxidative stress are hallmarks of aging.

Purpose of the Study:

  • To investigate the role of TAp73 in aging and its impact on mitochondrial activity and ROS homeostasis.
  • To identify the molecular mechanisms by which TAp73 influences aging processes.

Main Methods:

  • Utilized TAp73-null mouse models to study aging phenotypes.
  • Assessed cellular ATP levels, oxygen consumption, and mitochondrial complex IV activity.
  • Investigated the regulatory relationship between TAp73 and cytochrome C oxidase subunit 4 (Cox4i1).

Main Results:

  • TAp73-null mice displayed accelerated aging, increased oxidative damage, and senescence.
  • TAp73 deletion led to reduced cellular ATP, oxygen consumption, and mitochondrial complex IV activity.
  • TAp73 directly targets Cox4i1, a subunit of mitochondrial complex IV; Cox4i1 knockdown mimicked TAp73-null cellular senescence.

Conclusions:

  • TAp73 plays a crucial role in protecting against aging by regulating mitochondrial respiration and ROS levels.
  • TAp73's regulation of Cox4i1 is a key mechanism contributing to its anti-aging effects.
  • Targeting TAp73 or its downstream pathways may offer therapeutic strategies for age-related decline.

Related Concept Videos

Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...